This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...